FTC cracks down on GoodRx

The latest stories trending on MedCity News.

Editor's Pick

Top Story GoodRx Illegally Sold Users' Data to Google & Facebook, FTC Says GoodRx failed to notify users that it sold their personal health information to Google, Facebook and other tech companies, the FTC claimed. The agency filed an order that prohibits GoodRx from sharing its users' data with third parties for advertising purposes and requires the company to pay a $1.5 million penalty. Your Chance to Save $600 Ends Friday 2/3 Don't miss your opportunity to experience the premier networking event in healthcare. Join us May 22-24, 2023 at the Ritz Carlton in Chicago and get access to exclusive networking opportunities, mingle with investors and cutting edge startups, Ask CIOs, and so much more. Register Now

Featured News

Healthcare Consumers and Leaders Are Disserved by Subjective and Perception-based Rankings Instead of leaning on the arbitrary and subjective nature of prominent, perceived prestige-focused industry rankings, health systems must shift to a data-driven and mathematically sound approach to determining and benchmarking quality. Russian Hackers Take Down At Least 17 U.S. Health System Websites Russian hacker group Killnet has claimed responsibility for a string of recent cyberattacks that took more than a dozen hospital websites offline across the U.S. — including the websites for Cedars-Sinai, Michigan Medicine, and UPMC. The group has been active for at least a year and is known to target countries that support and/or send resources to Ukraine. FDA Asks Gene Therapy Biotech to Run Clinical Trial That Might Be Impossible Taysha Gene Therapies has encouraging data from an open-label, Phase 1/2 study in the rare disease giant axonal neuropathy. It might not be enough. The FDA recommended the biotech conduct a randomized and placebo-controlled study—a challenge in any ultra-rare disease. Data Breaches Continue to Wreak Havoc on Healthcare - Here's How to Make Security a Top Priority Security threats are not going away any time soon. In fact, they are on the rise and likely will be for years to come. Here are three ways to solve the most pressing problems.

Resources

Clinical Trial Design E-Book This eBook highlights how contract research organizations are collaborating with technology developers, the role that digital therapeutics could play in clinical trials, how companies are thinking about clinical trial diversity and the challenges in using real-world evidence to replicate clinical trials.   Download Now

MedCity News • 611 Broadway • New York, NY unsubscribe